It is a very low float, now with over 50 percent institutional and insider ownership, yet has only been an exciting stock for about one day -- when they first announced the licensing deal for the "women's Viagra".
As it's possible the stock could stay at these depressed prices a while, i sympathize with the exit, but I definitely think it's going to have a great ride at some point, and should be near 10 by end of year. The higher they go, the less dilutive their offerings should become -- and they'll make more, for new licenses -- and hopefully at some point they'll able to secure a grant too.
They have far from scored a touchdown yet, but their gameplay IMO really is an intriguing one. Anyway, up too early and babbling.
News 
Market Data 
Discover 
